학술논문

Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis
Document Type
Article
Source
In: Experimental Dermatology. (Experimental Dermatology, September 2023, 32(9):1531-1537)
Subject
Language
English
ISSN
16000625
09066705